Who Owns Mirum Pharmaceuticals Stock?
NASDAQ: MIRMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 111.76%
- Institutions (% of float)
- 113.25%
- Held by insiders
- 1.31%
- Institutional holders
- 442
- Institutions 98.7%
- Insiders 1.3%
- Public and other 0.0%
Who owns Mirum Pharmaceuticals stock?
Institutional investors own about 111.8% of Mirum Pharmaceuticals's shares, spread across 442 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.31% of MIRM.
The largest institutional holders are Frazier Life Sciences Management, L.P. (11.83%), Jupiter Topco LLC (9.10%) and Blackrock Inc. (6.76%). Together, the top 10 institutions control 52.2% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their MIRM positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MIRM
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.68M | 11.83% | 0.0% |
| Jupiter Topco LLC | 5.91M | 9.10% | +100.0% |
| Blackrock Inc. | 4.39M | 6.76% | +14.1% |
| FMR, LLC | 3.67M | 5.65% | +86.8% |
| Price (T.Rowe) Associates Inc | 2.66M | 4.09% | +54.6% |
| Vanguard Portfolio Management LLC | 2.38M | 3.66% | +66.0% |
| Vanguard Capital Management LLC | 2.25M | 3.47% | -6.7% |
| State Street Corporation | 2.17M | 3.34% | +11.6% |
| William Blair Investment Management, LLC | 1.40M | 2.16% | +318.5% |
| Geode Capital Management, LLC | 1.39M | 2.15% | +10.6% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MIRM
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.65M | 2.54% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.34M | 2.07% |
| iShares Trust-iShares Russell 2000 ETF | 1.21M | 1.86% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.19M | 1.83% |
| SmallCap World Fund Inc | 1.12M | 1.73% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.12M | 1.72% |
| T. Rowe Price New Horizons Fund, Inc. | 823.45K | 1.27% |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 791.87K | 1.22% |
| MUTUAL FUND SERIES TRUST-Eventide Gilead Fund | 709.13K | 1.09% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 686.32K | 1.06% |
Frequently asked questions
Who is the largest shareholder of Mirum Pharmaceuticals?
Frazier Life Sciences Management, L.P. is the largest institutional shareholder of MIRM, owning 11.83% of shares outstanding (7.68M shares) as of its latest 13F filing.
What percentage of Mirum Pharmaceuticals is owned by institutions?
Institutions own about 111.8% of MIRM shares and 113.2% of the public float.
How much of Mirum Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 1.31% of MIRM shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.